Entanglement distillation based on polarization and frequency hyperentanglement

Entanglement distillation has many applications in quantum information processing and is an important tool for improving the quality and efficiency of quantum communication, cryptography, computing, and simulation. We propose an entanglement distillation scheme using only one pair of polarization-frequency hyperentangled photons, which can be equivalently viewed as containing two pairs of entangled logical qubits: a pair of polarization-entangled qubits and a pair of frequency-entangled qubits. To perform the required CNOT operation between the two qubits we consider the use of a polarization-dependent frequency converter. Compared to past methods of entanglement distillation that relied on polarization and spatial-mode/energy-time degree of freedom, the utilization of frequency-encoded qubits offers an advantage in that it is immune to bit-flip errors when the channel is linear. After distillation, the fidelity of polarization entanglement can be significantly improved by sacrificing the frequency degree of freedom. Through simulation, we show that high fidelity gains, large yield, and high distillation rate can be achieved. Our distillation scheme is simple to implement with current technologies, compatible with existing telecommunication fiber networks, and is a promising approach for achieving efficient quantum communication.Comment: 9 pages, 5 figures, 1 tabl

A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance

The importance of mannitol has increased recently as an emerging diluent for orodispersible dosage forms. The study aims to prepare spray dried mannitol retaining high porosity and mechanical strength for the development of orally disintegrating tablets (ODTs). Aqueous feed of d-mannitol (10% w/v) comprising ammonium bicarbonate, NH4HCO3 (5% w/v) as pore former was spray dried at inlet temperature of 110-170°C. Compacts were prepared at 151MPa and characterized for porosity, hardness and disintegration time. Particle morphology and drying mechanisms were studied using thermal (HSM, DSC and TGA) and polymorphic (XRD) methods. Tablet porosity increased from 0.20±0.002 for pure mannitol to 0.53±0.03 using fabricated porous mannitol. Disintegration time dropped by 50-77% from 135±5.29s for pure mannitol to 75.33±2.52-31.67±1.53s for mannitol 110-170°C. Hardness increased by 150% at 110°C (258.67±28.89N) and 30% at 150°C (152.70±10.58N) compared to pure mannitol tablets (104.17±1.70N). Increasing inlet temperature resulted in reducing tablet hardness due to generation of 'micro-sponge'-like particles exhibiting significant elastic recovery. Impact of mannitol polymorphism on plasticity/elasticity cannot be ruled out as a mixture of α and β polymorphs formed upon spray drying

Electromagnetic Trapping of Cancer Cells on an Array of Thin-Film Permalloy Microfeatures for Single Cell Analysis

Isolation of individual cells from a bulk sample is vital in cell based diagnostics. Previous work has established the ability to arrange target cells into ordered arrays, using physical barriers such as micropillars and cups [1]. We here present a magnetic separation device that allows the tagged cells of interest to align into a highly ordered array where they are selected based on both immuno-markers and size. But, unlike the physical barrier methods, our device is able to trap the cells using an only 160-nm thin film of permalloy (80% Nickel, 20% Iron) micropatterned on the base of the chamber (Fig. 1). Maxima of the magnetic field arise in the vicinity of the sharp edges of these localized micro-spots (Fig. 2), thereby creating potential wells to localize paramagnetic bioparticles such as tagged cells or beads during analysis or successive washing steps (Fig. 3). Compared to a complex network of physical barriers, the trapped cells can simply be released by turning off the external magnet, allowing for further downstream analysis or removal to waste

Focal Ratio Degradation for Fiber Positioner Operation in Astronomical Spectrographs

Focal ratio degradation (FRD), the decrease of light’s focal ratio between the input into an optical fiber and the output, is important to characterize for astronomical spectrographs due to its effects on throughput and the point spread function. However, while FRD is a function of many fiber properties such as stresses, microbending, and surface imperfections, angular misalignments between the incoming light and the face of the fiber also affect the light profile and complicate this measurement. A compact experimental setup and a model separating FRD from angular misalignment was applied to a fiber subjected to varying stresses or angular misalignments to determine the magnitude of these effects. The FRD was then determined for a fiber in a fiber positioner that will be used in the Subaru Prime Focus Spectrograph (PFS). The analysis we carried out for the PFS positioner suggests that effects of angular misalignment dominate and no significant FRD increase due to stress should occur

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study

Background ‘Long COVID’ describes persistent symptoms, commonly fatigue, lasting beyond 12 weeks following SARS-CoV-2 infection. Potential causes include reduced mitochondrial function and cellular bioenergetics. AXA1125 has previously increased β-oxidation and improved bioenergetics in preclinical models along with certain clinical conditions, and therefore may reduce fatigue associated with Long COVID. We aimed to assess the efficacy, safety and tolerability of AXA1125 in Long COVID. Methods Patients with fatigue-dominant Long COVID were recruited in this single-centre, double-blind, randomised controlled phase 2a pilot study completed in the UK. Patients were randomly assigned (1:1) using an Interactive Response Technology to receive either AXA1125 or matching placebo in a clinical-based setting. Each dose (33.9 g) of AXA1125 or placebo was administered orally in a liquid suspension twice daily for four weeks with a two-week follow-up period. The primary endpoint was the mean change from baseline to day 28 in the phosphocreatine (PCr) recovery rate following moderate exercise, assessed by 31P-magnetic resonance spectroscopy (MRS). All patients were included in the intention to treat analysis. This trial was registered at ClinicalTrials.gov, NCT05152849. Findings Between December 15th 2021, and May 23th 2022, 60 participants were screened, and 41 participants were randomised and included in the final analysis. Changes in skeletal muscle phosphocreatine recovery time constant (τPCr) and 6-min walk test (6MWT) did not significantly differ between treatment (n = 21) and placebo group (n = 20). However, treatment with AXA1125 was associated with significantly reduced day 28 Chalder Fatigue Questionnaire [CFQ-11] fatigue score when compared with placebo (least squares mean difference [LSMD] −4.30, 95% confidence interval (95% CI) −7.14, −1.47; P = 0.0039). Eleven (52.4%, AXA1125) and four (20.0%, placebo) patients reported treatment-emergent adverse events; none were serious or led to treatment discontinuation. Interpretation Although treatment with AXA1125 did not improve the primary endpoint (τPCr-measure of mitochondrial respiration), when compared to placebo, there were significant improvements in fatigue-based symptoms among patients living with Long COVID following a four-week treatment period. Further multicentre studies are needed to validate our findings in a larger cohort of patients with fatigue-dominant Long COVID. Funding Axcella Therapeutics

Electrophysiologic actions of high plasma concentrations of propranolol in human subjects

The authors have previously shown that 40% of patients whose ventricular arrhythmias respond to propranolol require plasma concentrations in excess of those producing substantial beta-receptor blockade (> 150 ng/ml). However, the electrophysiologic actions of propranolol have only been examined in human beings after small intravenous doses achieving concentrations of less than 100 ng/ml. In this study, the electrophysiologic effects of a wider concentration range of propranolol was examined in nine patients. Using a series of loading and maintenance infusions, measurements were made at baseline, at low mean plasma propranolol concentrations (104 ± 17 ng/ml) and at high concentrations (472 ± 68 ng/ml). Significant (p < 0.05) increases in AH interval and sinus cycle length were seen at low concentrations of propranolol, with no further prolongation at the high concentrations; these effects are typical of those produced by beta-blockade. However, progressive shortening of the endocardial monophasic action potential duration and QTc interval were seen over the entire concentration range tested (p < 0.05). At high concentrations, there was significant (p < 0.05) further shortening of both the QTc and monophasic action potential duration beyond that seen at low propranolol concentrations, along with a progressive increase in the ratio of the ventricular effective refractory period to monophasic action potential duration. No significant changes were seen in HV interval, QRS duration or ventricular effective refractory period.In summary, the concentration-response relations for atrioventricular conductivity and sinus node automat-icity were flat above concentrations of 150 ng/ml. On the other hand, the durations of the monophasic action potential and the QTc interval shortened at high concentrations. It is concluded that propranolol, in addition to blocking beta-receptors, produces other beta-receptor independent electrophysiologic effects in human beings

Insight Into the Formation of the Milky Way Through Cold Halo Substructure. I. The ECHOS of Milky Way Formation

We identify ten -- seven for the first time -- elements of cold halo substructure (ECHOS) in the volume within 17.5 kpc of the Sun in the inner halo of the Milky Way. Our result is based on the observed spatial and radial velocity distribution of metal-poor main sequence turnoff (MPMSTO) stars in 137 Sloan Extension for Galactic Understanding and Exploration (SEGUE) lines of sight. We point out that the observed radial velocity distribution is consistent with a smooth stellar component of the Milky Way's inner halo overall, but disagrees significantly at the radial velocities that correspond to our detections. We show that all of our detections are statistically significant and that we expect no false positives. We also use our detections and completeness estimates to infer a formal upper limit of 0.34 +/- 0.02 on the fraction of the MPMSTO population in the inner halo that belong to ECHOS. Our detections and completeness calculations suggest that there is a significant population of low fractional overdensity ECHOS in the inner halo, and we predict that 1/3 of the inner halo (by volume) harbors ECHOS with MPMSTO star number densities n ~ 15 kpc^-3. ECHOS are likely older than known surface brightness substructure, so our detections provide us with a direct measure of the accretion history of the Milky Way in a region and time interval that has yet to be fully explored. In concert with previous studies, our result suggests that the level of merger activity has been roughly constant over the past few Gyr and that there has been no accretion of single stellar systems more massive than a few percent of a Milky Way mass in that interval. (abridged)Comment: 47 pages, 23 figures, and 6 tables in emulaetapj format; accepted for publication in Ap